AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Study Evaluating the Effectiveness of Intraoperative Ventilation for Predicting Postoperative Air Leaks During Major Lung Resections by Conventional or Robotic Thoracoscopy

Recruitingn/aAges 18 Years - anyAllGCS Ramsay Santé pour l'Enseignement et la Recher…
💬

In plain words

What the trial is, and whether it could suit you

Air leak from lung after major pulmonary resections is alveolar-pleural microfistulas resulting from damage to the visceral pleura during lung surgery. Despite advances in stapling techniques and repair methods to ensure pulmonary tightness after excision, air leak is the most common cause of prolonged hospital stay after lung surgery, accounting for 20 to 30% of post-surgical adverse events. Although painless, they remain a significant source of morbidity. 10 to 20% of patients may have a prolonged air leak requiring intervention. Prolonged air leak is defined as an air leakage that persists for 5 days or more. Prolonged air leak is independently associated with increased hospitalization costs of 18% to 27% according to the series reported in the literature, but also with increased costs after hospital discharge, up to 90 days postoperatively. Traditionally, the detection of air leak

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patient with pulmonary lobectomy or Anatomical segmentectomy with closed chest (conventional or robotic thoracoscopy); * Patient affiliated with a health insurance scheme. * Person who has not objected to the collection of his/her data for the purpose of the study. Exclusion Criteria: * Patient undergoing any type of lung resection by thoracotomy; * Patient with a history of thoracic surgery on the same side; * Patient with pulmonary fibrosis; * Patient from a vulnerable population as defined in Articles L.1121-5 to 8 of the French Public Health Code. * Patient undergoing conversion to thoracotomy; * Patient undergoing conversion from planned pulmonary lobectomy or anatomical segmentectomy to atypical resection, bilobectomy or pneumonectomy; * Drainage via two chest drains; * Absence of autonomous drainage system; * Patient not extubated at the end of the procedure; * Early reoperation, before drain removal, due to complications.
💊

What it tests

  • No Intervention: Observational Cohort
📍

Where

1 site
Hôpital privé d'Anthony
Antony, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy